1
Bioequivalence Study of Raperazole 20mg DR Tabs and PARIET® 20 mg DR Tabs Under Fed Conditions
Condition(s):Gastrointestinal DiseasesLast Updated:October 1, 2018Completed
Rabeprazole Sodium DR: 9 Clinical Trials
Hide Studies Not Open or Pending
2
A Bioequivalence Study of Idiazole 20mg DR Tabs and PARIET® 20 mg DR Tabs After a Single Oral Dose Administration Under Fasting Conditions in Healthy Adults
Condition(s):Gastrointestinal DiseasesLast Updated:November 17, 2017Completed
3
A Bioequivalence Study of Rabeprazole From Idiazole 20mg DR Tabs (GSK, Egypt) and PARIET 20 mg DR Tabs (JANSSEN, EGYPT)
Condition(s):HealthyLast Updated:June 22, 2015Completed
4
10 vs 14 Days Triple Therapy : H.Pylori Infection Eradication
Condition(s):Helicobacter Pylori InfectionLast Updated:April 28, 2017Unknown status
5
A Study of the Use of High-dose Proton Pump Inhibitor for the Treatment of Gastro-oesophageal Reflux Related Non-cardiac Chest Pain – a Randomized Double-blind Placebo-controlled Study
Condition(s):Chest PainLast Updated:July 7, 2010Unknown status
6
A Study in Healthy Subjects to Assess Bioavailability (Proportion of a Drug Which Enters the Circulation to Have an Active Effect) of Acalabrutinib Tablet and Protonpump Inhibitor Effect (Members of a Class of Medications That Inhibits in Gastric Acid Production) for Rabeprazole
Condition(s):Mantle Cell Lymphoma; COVID-19Last Updated:December 29, 2020Completed
7
Prospective Double-blinded Randomized Controlled Trial of 12-weeks High Dose Rabeprazole (Pariet) in the Treatment of Reflux Laryngitis in Chinese Patients
Condition(s):Gastroesophageal Reflux; LaryngitisLast Updated:October 23, 2013Completed
8
Improvement in Bronchial Asthma in Patients With Extraesophageal Reflux After Acid Suppression
Condition(s):Bronchial Asthma; Gastroesophageal RefluxLast Updated:July 22, 2011Completed
9
Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients With Rabeprazole
Condition(s):Gastroesophageal Reflux DiseaseLast Updated:December 3, 2009Completed